echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New options for head and neck cancer treatment

    New options for head and neck cancer treatment

    • Last Update: 2022-05-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Head and neck cancer is the sixth most common form of cancer worldwide, with approximately 500,000 deaths each year


    Over the course of their study, the researchers were able to identify a protein that could be used to predict the average survival rate of patients with HPV-positive head and neck cancer and make treatment progress


    prognostic marker

    The most common triggers for head and neck tumors are still drinking and smoking


    Targeted therapy

    CBP inhibitors are drugs currently in development that could be available in the next few years




    Provided by the University of Vienna


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.